Bank Hapoalim BM Takes Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Bank Hapoalim BM acquired a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 51,000 shares of the pharmacy operator's stock, valued at approximately $570,000.

Other hedge funds also recently modified their holdings of the company. Central Pacific Bank Trust Division lifted its position in Walgreens Boots Alliance by 28.6% in the first quarter. Central Pacific Bank Trust Division now owns 4,500 shares of the pharmacy operator's stock worth $50,000 after purchasing an additional 1,000 shares during the period. Harbour Investments Inc. lifted its position in Walgreens Boots Alliance by 4.3% in the fourth quarter. Harbour Investments Inc. now owns 28,389 shares of the pharmacy operator's stock worth $265,000 after purchasing an additional 1,165 shares during the period. Unison Advisors LLC lifted its position in Walgreens Boots Alliance by 2.8% in the fourth quarter. Unison Advisors LLC now owns 43,226 shares of the pharmacy operator's stock worth $403,000 after purchasing an additional 1,168 shares during the period. Avantax Advisory Services Inc. lifted its position in Walgreens Boots Alliance by 2.4% in the fourth quarter. Avantax Advisory Services Inc. now owns 49,896 shares of the pharmacy operator's stock worth $466,000 after purchasing an additional 1,186 shares during the period. Finally, HBK Sorce Advisory LLC lifted its position in Walgreens Boots Alliance by 10.4% in the fourth quarter. HBK Sorce Advisory LLC now owns 12,591 shares of the pharmacy operator's stock worth $117,000 after purchasing an additional 1,188 shares during the period. 58.59% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research analysts recently commented on the company. Wall Street Zen assumed coverage on Walgreens Boots Alliance in a research report on Wednesday, May 21st. They issued a "hold" rating for the company. Morgan Stanley reiterated an "underweight" rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Finally, UBS Group reiterated a "neutral" rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $10.59.

Insider Transactions at Walgreens Boots Alliance

In other news, Chairman Stefano Pessina acquired 832,258 shares of the firm's stock in a transaction that occurred on Sunday, April 27th. The stock was purchased at an average price of $11.01 per share, for a total transaction of $9,163,160.58. Following the completion of the acquisition, the chairman owned 145,621,079 shares in the company, valued at $1,603,288,079.79. This trade represents a 0.57% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 17.50% of the company's stock.

Walgreens Boots Alliance Trading Down 0.3%

Shares of WBA traded down $0.03 on Tuesday, reaching $11.52. 6,401,981 shares of the company's stock were exchanged, compared to its average volume of 19,565,539. The stock has a market capitalization of $9.97 billion, a P/E ratio of -1.58, a price-to-earnings-growth ratio of 1.35 and a beta of 0.78. The business has a 50 day moving average price of $11.27 and a two-hundred day moving average price of $10.91. The company has a current ratio of 0.60, a quick ratio of 0.32 and a debt-to-equity ratio of 0.96. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $13.25.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its quarterly earnings data on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.34 by $0.04. The firm had revenue of $38.99 billion during the quarter, compared to analysts' expectations of $36.72 billion. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The business's revenue for the quarter was up 7.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.63 earnings per share. Research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.